α-methyltryptophan-mediated protection against diabetic nephropathy in db/db mice as studied with a metabolomics approach
IntroductionDiabetic nephropathy (DN), a major complication of diabetes, presents with poor clinical outcomes and affects patients throughout their lifetime. α-Methyltryptophan (α-MT) is a blocker of the amino acid transporter. SLC6A14 and also an inhibitor of indoleamine 2,3-dioxygenase-1 (IDO1).Me...
Saved in:
Main Authors: | Aimin Cai, Dingchao Shen, Qiushuang Xiong, Jie Ding, Yang Ding, Xinlu Lin, Lijia Chen, Qing Yao, Guangyong Lin, Ruijie Chen, Vadivel Ganapathy, Longfa Kou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1463673/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mTOR pathway: A key player in diabetic nephropathy progression and therapeutic targets
by: Jingxuan Shi, et al.
Published: (2025-03-01) -
Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms
by: Sulaiman K. Marafie, et al.
Published: (2024-12-01) -
Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in db/db Mice Using Cytokine Antibody Array
by: Xue Mei Fan, et al.
Published: (2018-01-01) -
Porphyra haitanensis polysaccharide (PH) attenuates cell hyperplasia via remodeling the cross-talk between Hippo/YAP and mTOR pathways
by: Chong Wang, et al.
Published: (2023-03-01) -
Apigenin suppresses osteoarthritis progression by inhibiting pyroptosis via SIRT1/mTOR pathway-mediated mitophagy
by: Jiahao Ying, et al.
Published: (2025-01-01)